Bone Morphogenetic Proteins Market

Global Bone Morphogenetic Proteins Market Size, Share & Trends Analysis Report, By Type (rhBMP-2 and rhBMP-7), By Application (Trauma, Oral Maxillofacial Surgery, Reconstruction, and Spinal Fusion), Forecast (2021-2027)

Published: Jan 2022 | Report Code: OMR2025582 | Category : Pharmaceuticals | Delivery Format: /

The global bone morphogenetic proteins market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to propel the market growth include the growth in the incidences of sports-related injuries, the growing demand for minimally invasive surgeries, and technological advancements in the field of bone morphogenetic protein. According to the Centers for Disease Control and Prevention (CDC), the number of people participating in sports is increasing across both developing and developed nations, and this is ultimately leading to an increased number of sports injuries. Approximately, 8.6 million individuals are getting injured during sports annually, as stated by the National Institute of Health (NIH), 2016. This accounts for 34.1 people per 1,000. Spinal injury is the most frequent injury that was seen among the injured population during the NIH survey.

As the number of such sports-related injuries are increasing, there is a growing demand for bone morphogenetic protein, as this protein supports people who require to obtain bone formation. Bone morphogenetic proteins (BMPs) are signalling molecules and most are a part of the Transforming Growth Factor-? (TGF?) family of proteins. BMPs have an important role in bone and cartilage formation, and embryogenesis. Bone morphogenetic protein (BMP) is a protein that stimulates the formation of bone in the body and it is widely used in spinal fusion surgery. Studies have revealed that BMP is accepted widely to facilitate the fusion at a rate greater than that of traditional bone graft surgery. Due to this cause, BMP gives the surgeon the freedom to perform the surgery with the ease of the improved fusion rate, which avoids the complications of an iliac crest autograft (hip) graft harvest.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape: Olympus Corp., Medtronic plc, and Ember Therapeutics, Inc., among others. 

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Bone Morphogenetic Proteins Market Report by Segment

By Type

rhBMP-2

rhBMP-7

By Application

Trauma

Oral Maxillofacial Surgery

Reconstruction

Spinal Fusion

Global Bone Morphogenetic Proteins Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World